- Previous Close
13.04 - Open
12.94 - Bid 13.11 x --
- Ask 13.12 x --
- Day's Range
12.92 - 13.23 - 52 Week Range
10.84 - 23.22 - Volume
4,663,800 - Avg. Volume
6,407,402 - Market Cap (intraday)
7.683B - Beta (5Y Monthly) 0.72
- PE Ratio (TTM)
50.46 - EPS (TTM)
0.26 - Earnings Date --
- Forward Dividend & Yield 0.40 (3.05%)
- Ex-Dividend Date May 30, 2024
- 1y Target Est
15.21
Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, operates a chain of drugstores in China. It also produces and sells medicinal materials, Chinese herbal medicines, and food and health products, as well as engages in the drug distribution activities. It operates stores in Yunnan, Guizhou, Guangxi, Sichuan, Shanxi, Chongqing, Tianjin, Shanghai, Qiong, and other provinces and municipalities. It also sells products online. The company was formerly known as Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. and changed its name to Yixintang Pharmaceutical Group Co., Ltd. in June 2019. Yixintang Pharmaceutical Group Co., Ltd. was founded in 2000 and is headquartered in Kunming, China.
www.hx8886.com35,024
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 002727.SZ
View MorePerformance Overview: 002727.SZ
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002727.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002727.SZ
View MoreValuation Measures
Market Cap
7.68B
Enterprise Value
7.56B
Trailing P/E
50.93
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.43
Price/Book (mrq)
1.00
Enterprise Value/Revenue
0.42
Enterprise Value/EBITDA
17.27
Financial Highlights
Profitability and Income Statement
Profit Margin
0.86%
Return on Assets (ttm)
1.90%
Return on Equity (ttm)
2.21%
Revenue (ttm)
18.16B
Net Income Avi to Common (ttm)
156.02M
Diluted EPS (ttm)
0.26
Balance Sheet and Cash Flow
Total Cash (mrq)
3.24B
Total Debt/Equity (mrq)
39.58%
Levered Free Cash Flow (ttm)
1.88B